Precigen to Participate in the 2022 Wells Fargo Healthcare Conference

GERMANTOWN, Md., Sept. 1, 2022 /PRNewswire/ — Precigen, Inc. (NASDAQ: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will…

Click here to view original post